Publications en collaboration avec des chercheurs de Universidad de Salamanca (11)

2024

  1. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

  2. Strategies to enhance the response of liver cancer to pharmacological treatments

    American journal of physiology. Cell physiology, Vol. 327, Núm. 1, pp. C11-C33

2023

  1. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity

    Cells, Vol. 12, Núm. 8

2022

  1. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

    Cancers, Vol. 14, Núm. 14

  2. Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies

    Cancers, Vol. 14, Núm. 14

2021

  1. Association of foxo3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: A systematic review with meta-analysis

    Cancers, Vol. 13, Núm. 21

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

    Aging, Vol. 13, Núm. 19, pp. 23416-23434

2003

  1. TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor Kappa B activation in a rat model of hepatocellular carcinoma

    Free Radical Research, Vol. 37, Núm. 8, pp. 841-848

2002

  1. Choleresis and inhibition of biliary lipid secretion induced by piperacillin in the rat

    Clinical and Experimental Pharmacology and Physiology, Vol. 29, Núm. 10, pp. 880-884

2000

  1. Enhancement of bile acid pool size, synthesis and secretion by epomediol in the rat

    Digestive Diseases and Sciences, Vol. 45, Núm. 7, pp. 1431-1438